The down-regulation of PI3K and ERK pathway by PI3K and ERK inhibitors could inhibit the cell proliferation and migration in HCC cells and the production of CXCL8 and CXCL5 from HCC cells. This evidence concerns the gene CXCL8 and hepatocellular carcinoma.